IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes

被引:361
作者
Moreau, P
Adrian-Cabestre, F
Menier, C
Guiard, V
Gourand, L
Dausset, J
Carosella, ED
Paul, P
机构
[1] Hop St Louis, Ctr Hayem, DSV, DRM,CEA,Serv Rech Hematoimmunol, F-75010 Paris, France
[2] Hop Bluets, F-75011 Paris, France
[3] Ctr Etud Polymorphisme Humain, Fdn Jean Dausset, F-75010 Paris, France
关键词
HLA-G; modulation; IL-10; monocytes; trophoblasts;
D O I
10.1093/intimm/11.5.803
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
HLA-G prays an essential role in fete-maternal tolerance by inhibiting lysis by maternal NK cells. The factors that allow tissue-specific activation of HLA-G gene expression in trophoblasts remain to be characterized. We investigated the potential effect of IL-10, a cytokine which is secreted in placenta, on HLA-G gene transcription in trophoblasts. Using Northern blot, RNase protection assay and RT-PCR analysis, we demonstrated that IL-10 enhances steady-state levels of HLA-G transcription in cultured trophoblast cells. We further tested the effect of IL-10 on HLA-G gene transcription and protein expression in peripheral blood monocytes, showing that IL-10 can upregulate HLA-G cell surface expression in this cell type. This effect of IL-10 is selective, since classical MHC class I products and MHC class II are down-regulated in monocytes following IL-10 treatment. Induction of HLA-G expression by IL-10 on monocytes may thus play a role in downregulation of the immune response, We propose that IL-10 secretion by trophoblasts during pregnancy may also influence the HLA class I expression pattern at the fete-maternal barrier, thus protecting the fetus from rejection. This should be taken into consideration in the design of treatment for pathologies of pregnancy.
引用
收藏
页码:803 / 811
页数:9
相关论文
共 70 条
[1]  
ADRIANCABESTRE F, IN PRESS J REPROD IM
[2]  
Allavena P, 1998, EUR J IMMUNOL, V28, P359, DOI 10.1002/(SICI)1521-4141(199801)28:01<359::AID-IMMU359>3.0.CO
[3]  
2-4
[4]   HLA-G class I gene expression in normal and malignant hematopoietic cells [J].
Amiot, L ;
Onno, M ;
Drénou, B ;
Monvoisin, C ;
Fauchet, R .
HUMAN IMMUNOLOGY, 1998, 59 (08) :524-528
[5]   IL-10 is a key cytokine in psoriasis -: Proof of principle by IL-10 therapy:: A new therapeutic approach [J].
Asadullah, K ;
Sterry, W ;
Stephanek, K ;
Jasulaitis, D ;
Leupold, M ;
Audring, H ;
Volk, HD ;
Döcke, WD .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (04) :783-794
[6]   HIGH-LEVELS OF INTERLEUKIN-10 PRODUCTION IN-VIVO ARE ASSOCIATED WITH TOLERANCE IN SCID PATIENTS TRANSPLANTED WITH HLA MISMATCHED HEMATOPOIETIC STEM-CELLS [J].
BACCHETTA, R ;
BIGLER, M ;
TOURAINE, JL ;
PARKMAN, R ;
TOVO, PA ;
ABRAMS, J ;
MALEFYT, RD ;
DEVRIES, JE ;
RONCAROLO, MG .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (02) :493-502
[7]   MOLECULAR CHARACTERIZATION OF MURINE AND HUMAN OX40/OX40 LIGAND SYSTEMS - IDENTIFICATION OF A HUMAN OX40 LIGAND AS THE HTLV-1-REGULATED PROTEIN GP34 [J].
BAUM, PR ;
GAYLE, RB ;
RAMSDELL, F ;
SRINIVASAN, S ;
SORENSEN, RA ;
WATSON, ML ;
SELDIN, MF ;
BAKER, E ;
SUTHERLAND, GR ;
CLIFFORD, KN ;
ALDERSON, MR ;
GOODWIN, RG ;
FANSLOW, WC .
EMBO JOURNAL, 1994, 13 (17) :3992-4001
[8]  
Bennett WA, 1996, AM J REPROD IMMUNOL, V36, P285
[9]   ALTERED BINDING OF REGULATORY FACTORS TO HLA CLASS-I ENHANCER SEQUENCE IN HUMAN TUMOR-CELL LINES LACKING CLASS-I ANTIGEN EXPRESSION [J].
BLANCHET, O ;
BOURGE, JF ;
ZINSZNER, H ;
ISRAEL, A ;
KOURILSKY, P ;
DAUSSET, J ;
DEGOS, L ;
PAUL, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (08) :3488-3492
[10]   Endothelial cells in chorionic fetal vessels of first trimester placenta express HLA-G [J].
Blaschitz, A ;
Lenfant, F ;
Mallet, V ;
Hartmann, M ;
Bensussan, A ;
Geraghty, DE ;
Le Bouteiller, P ;
Dohr, G .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (12) :3380-3388